SEC Company Response from ASSEMBLY BIOSCIENCES, INC. (ASMB) (CIK 0001426800) (ASMB) — Jan 8, 2018
ASSEMBLY BIOSCIENCES, INC. (ASMB) (CIK 0001426800)
Date: Jan. 8, 2018 · CIK: 0001426800 · Accession: 0001144204-18-001270
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-222366
Letter
Re: Assembly Biosciences, Inc.
VIA EDGAR
January 8, 2018
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Acceleration Request for Registration Statement on Form S-3
File No. 333-222366
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), Assembly Biosciences, Inc. (the “Company”) hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to January 10, 2018, at 4:01 pm Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.
If you have any questions regarding this request, please contact Maggie Wong of Goodwin Procter LLP at (415) 733-6071.
Sincerely,
Assembly
biosciences, inc.
Show Raw Text
CORRESP
1
filename1.htm
VIA EDGAR
January 8, 2018
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re:
Assembly Biosciences, Inc.
Acceleration Request for Registration Statement on Form S-3
File No. 333-222366
Ladies and Gentlemen:
Pursuant
to Rule 461 under the Securities Act of 1933, as amended (the “Act”), Assembly Biosciences, Inc. (the “Company”)
hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”)
be accelerated to January 10, 2018, at 4:01 pm Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel,
Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective at some other time. In making
this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.
If
you have any questions regarding this request, please contact Maggie Wong of Goodwin Procter LLP at (415) 733-6071.
Sincerely,
Assembly
biosciences, inc.
/s/
Elizabeth H. Lacy
Name:
Elizabeth H. Lacy
Title:
General Counsel, VP of Legal
Operations
Corporate Secretary
cc:
Mitchell Bloom, Goodwin
Procter LLP
David Barrett, Assembly
Biosciences, Inc.
John Gunderson, Assembly
Biosciences, Inc.
HQ:
11711 N. Meridian Street, Suite 310, Carmel, IN 46032
R&D:
409 Illinois St., San Francisco, CA 94158 and 93 Shennecossett Rd., Groton, CT 06340
www.assemblybio.com
| info@assemblybio.com